The Respiratory Diseases Drugs Market To Improve Its Performance

1. Respiratory Diseases Drugs Respiratory Diseases Drugs Global Market Report 2019 Report 2019 Global Market © The Business Research Company. All rights reserved. www.tbrc.info Email: info@tbrc.info

2. Topics Covered • Respiratory Diseases Drugs Global Market Size • Respiratory Diseases Drugs Global Market Trend • Respiratory Diseases Drugs Global Market Segmentation Respiratory Diseases Drugs Global Market Report 2019 2 © The Business Research Company. All rights reserved.

3. Introduction- The respiratory diseases drugs market consists of sales of respiratory diseases drugs and related services by entities (organizations, sole traders and partnerships) that produce drugs to treat respiratory diseases such as asthma, acute bronchitis, emphysema, cystic fibrosis and other diseases. This industry includes establishments that produce anti-asthmatics and COPD drugs to prevent acute attacks caused by respiratory diseases and cough and cold preparations to treat cough and cold. Click here to get a sample of this report 3 © The Business Research Company. All rights reserved.

4. Companies covered- • GlaxoSmithKline Plc, • AstraZeneca Plc, • Merck & Co, • Novartis AG, • Johnson & Johnson. Click here to get a sample of this report 4 © The Business Research Company. All rights reserved.

5. Countries Covered • USA • China • Germany • Brazil • Japan • UK • Spain • Russia • France • Australia • Italy • India • Rest of the world Click here to get a sample of this report 5 © The Business Research Company. All rights reserved.

6. Respiratory Diseases Drugs Global Market Trend The demand for PSE-containing cold, allergy, and sinus products is growing due to their effectiveness and convenience. PSE is an active ingredient found in various cold, allergy, and sinus drugs that can provide congestion relief. However, PSE-containing medicines are mostly sold as a prescription drug, as PSE can also be used for the illegal manufacture of methamphetamine, a recreational drug. This has led drug manufacturers to produce tamper-resistant PSE products. For instance, in March 2017, pharmaceutical companies Acura Pharmaceuticals Inc. and MainPointe Pharmaceuticals LLC entered into an agreement, enabling MainPointe Pharmaceuticals LLC to market NEXAFED and NEXAFED Sinus products in the US and Canada. These drugs utilize tamper-resistant PSE formulation to prevent the illicit production of methamphetamine. Click here to get a sample of this report 6 © The Business Research Company. All rights reserved.

7. Click here to get a sample of this report © The Business Research Company. All rights reserved.

8. Respiratory Diseases Drugs Global Market Segmentation • By type and • By geography Click here to get a sample of this report 8 © The Business Research Company. All rights reserved.

9. Critical Data Points Metrics Indicators Metrics Indicators Facilities, Employees, Consumption, Expenditure Segmented By Age, Sex, Behaviour, Attitudes Market Sales, Sales By Segment Sales Data # Enterprises Market Shares Sales Of Leading Competitors # Customers Units/ Volumes/ Weights Sales/ Stock Import And Export Values And Volumes Units Sold Economics Data Output, Income Imports & Exports Houses, Roads, Schools And Hospitals Infrastructure Production Data Output, Capacity Procedures, Transactions, Contracts # Processes 9

10. Across 11 Countries and 5 Regions Russia Europe UK Germany France Italy Spain Asia China USA Japan Middle East & Africa India Americas Brazil Oceania

11. Get In Touch Whatever your need be, at The Business Research Company we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. 11 © The Business Research Company. All rights reserved.

12. Related Reports https://www.thebusinessresearchcompany.com/report/biolog ics-global-market-opportunities-and-strategies-to-2021 https://www.thebusinessresearchcompany.com/report/cardio vascular-drugs-global-market-report https://www.thebusinessresearchcompany.com/report/derm atology-drugs-global-market-report 12 © The Business Research Company. All rights reserved.

13. Offerings 13 © The Business Research Company. All rights reserved.

14. Testimonials "The Business Research Company provides reliable and useful information for the technology sector" Janardhan Rajan, Senior Consultant, Tech Mahindra (IT Services) “An excellent provider. Thorough, timely and with outstanding insight delivered in an easily digestible format.” Paul Thompson, Director, Barclays Bank “The Business Research Company has an ideal offering for modern media companies. Whether it is finding details of potential customers, doing primary interviews, or large scale data gathering, its services are ideally suited and well priced.” Robert Mannix, Insurance Risk Editor, Incisive Media “The Business Research Company were very responsive and were able to access critical business information rapidly as a result of their deep knowledge of the (Indian) market. I would recommend them wholeheartedly.” Lawrence Dore, Partner, Davidson, Ryan, Dore, (Consultancy) 14

15. Follow us on our social media and message us! 15 © The Business Research Company. All rights reserved.

16. Europe Asia Americas The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info 16 © The Business Research Company. All rights reserved.